Voice your opinion on congressional bill HR2706-117 and let lawmakers know your stance with UnPac!

Main Subject: Health

Freedom from Price Gouging Act

This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under Medicare that cost $100 or more and for which the average manufacturer price increases faster than inflation.

HR3-117, HR5376-117, HR5260-117, HR5237-117,

House committee actions Actions

Committee
Apr. 21 2021	Referred to the Subcommittee on Health.
Apr. 20 2021	Referred to the Subcommittee on Social Security. Referred to the Subcommittee on Health.

House floor actions Actions

IntroReferral

Apr. 20
2021

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Library of Congress Actions

IntroReferral
Apr. 20 2021	Introduced in House Introduced in House

House bill HR2706-117

Freedom from Price Gouging Act

Promote the cause!

Or use this QR code